Cognitive correlates of 1H MRS measures in the healthy elderly brain

Ageing is associated with cognitive decline, with some studies indicating that this decline can be mostly accounted for by slowing of information processing speed. Whilst it is likely that this is associated with age-related changes in fronto-subcortical neuronal circuits, such changes are not visible on routine neuroimaging. We examined the integrity of this brain region using proton magnetic resonance spectroscopy (1H MRS) and hypothesised that functional changes measured by 1H MRS would be associated with cognitive performance. Fifty-nine healthy elderly subjects (age 58-85 years) underwent single-voxel 1H MRS in frontal white matter and occipito-parietal gray matter, and a comprehensive neuropsychological battery. The results showed a significant correlation between frontal white matter NAA/H2O and a composite measure of neuropsychological performance representing speed of information processing, attentional function and visual memory, controlling for age and sex. This research highlights the importance of the relationship between regional brain changes and cognitive function in the ageing brain, and suggests that MRS may be a sensitive marker of subclinical change in cognition.

[1]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[2]  H. Bachelard,et al.  NMR Spectroscopy in Neurochemistry , 1993, Journal of Neurochemistry.

[3]  K O Lim,et al.  In vivo brain concentrations of N-acetyl compounds, creatine, and choline in Alzheimer disease. , 1999, Archives of general psychiatry.

[4]  K. Michals‐Matalon,et al.  Biochemistry and Molecular Biology of Canavan Disease , 1999, Neurochemical Research.

[5]  R. Haaxma,et al.  The mental status examination in neurology. F. A. Davis Company (1977), 182 pp., Price Fl. 24,25 , 1978 .

[6]  Roberto Cabeza,et al.  Aging Gracefully: Compensatory Brain Activity in High-Performing Older Adults , 2002, NeuroImage.

[7]  Brain research bulletin , 1984, Pharmacology Biochemistry and Behavior.

[8]  H. Brodaty,et al.  The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients , 2004, Neurology.

[9]  J. Greene.  Contributions to Neuropsychological Assessment , 1995 .

[10]  V. Henderson,et al.  Boston Naming Test: shortened versions for use in Alzheimer's disease. , 1992, Journal of gerontology.

[11]  P. Sachdev.  The Ageing Brain , 2003 .

[12]  Paul B. Baltes,et al.  Intellectual Development in Adulthood: The Seattle Longitudinal Study , 1996 .

[13]  M Noble,et al.  Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.

[14]  W. Reddick,et al.  Establishing norms for age-related changes in proton T1 of human brain tissue in vivo. , 1997, Magnetic resonance imaging.

[15]  Kevin M Bradley,et al.  Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. , 2002, Brain : a journal of neurology.

[16]  H. Brodaty,et al.  Dual Voxel Proton Magnetic Resonance Spectroscopy in the Healthy Elderly: Subcortical-Frontal Axonal N-Acetylaspartate Levels Are Correlated with Fluid Cognitive Abilities Independent of Structural Brain Changes , 2000, NeuroImage.

[17]  N. Bargalló,et al.  Relationship among 1H-magnetic resonance spectroscopy, brain volumetry and genetic polymorphisms in humans with memory impairment , 2002, Neuroscience Letters.

[18]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .

[19]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[20]  E. Tulving,et al.  Age‐related differences in effective neural connectivity during encoding and recall , 1997, Neuroreport.

[21]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[22]  P A Narayana,et al.  In vivo proton magnetic resonance spectroscopy studies of human brain. , 1991, Magnetic resonance imaging.

[23]  R. DeTeresa,et al.  Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.

[24]  Ian Marshall,et al.  Magnetic resonance spectroscopy and cognitive function in healthy elderly men. , 2002, Brain : a journal of neurology.

[25]  A. Hofman,et al.  1H chemical shift imaging of the human brain at age 60–90 years reveals metabolic differences between women and men , 1999, Magnetic resonance in medicine.

[26]  R. Sutherland,et al.  The aging hippocampus: cognitive, biochemical and structural findings. , 2003, Cerebral cortex.

[27]  B L Hart,et al.  Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. , 1999, Neuroreport.

[28]  Amy J. Ross,et al.  Magnetic resonance spectroscopy in cognitive research , 2004, Brain Research Reviews.

[29]  M. D’Esposito,et al.  The Influence of Working-Memory Demand and Subject Performance on Prefrontal Cortical Activity , 2002, Journal of Cognitive Neuroscience.

[30]  B. Lerer,et al.  Age-related changes in brain perfusion of normal subjects detected by 99mTc-HMPAO SPECT , 1998, Neuroradiology.

[31]  K Warner Schaie,et al.  Longitudinal invariance of adult psychometric ability factor structures across 7 years. , 1998, Psychology and aging.

[32]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[33]  D K Ingram,et al.  What counts in brain aging? Design-based stereological analysis of cell number. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[34]  J E Desmond,et al.  Age differences in prefrontal cortical activity in working memory. , 2001, Psychology and aging.

[35]  N Roberts,et al.  A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. , 2001, Cerebral cortex.

[36]  Norbert Schuff,et al.  Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging☆ , 1999, Neurobiology of Aging.

[37]  E G Tangalos,et al.  Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease , 2000, Neurology.

[38]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[39]  L. Kappelle,et al.  Cerebral metabolic changes in patients with a symptomatic occlusion of the internal carotid artery: A longitudinal 1H magnetic resonance spectroscopy study , 2000, Journal of magnetic resonance imaging : JMRI.

[40]  L Symon,et al.  Investigation into the Role of N‐Acetylaspartate in Cerebral Osmoregulation , 1995, Journal of neurochemistry.

[41]  J. Barth,et al.  The Halstead-Reitan Neuropsychological Test Battery. , 2000 .

[42]  E. Sullivan,et al.  Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease , 2000, The Lancet.

[43]  Barbara Palumbo,et al.  Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging , 1997, Mechanisms of Ageing and Development.

[44]  P. S. Achilles.  THE PSYCHOLOGICAL CORPORATION. , 1923, Science.

[45]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[46]  K. Krishnan,et al.  Prediction of cognitive decline in early Alzheimer's disease , 1998, The Lancet.

[47]  D. Graham,et al.  Aging‐associated Changes in Human Brain , 1997, Journal of neuropathology and experimental neurology.

[48]  A Hofman,et al.  Human Brain Chemical Shift Imaging at Age 60 to 90: Analysis of the Causes of the Observed Sex Differences in Brain Metabolites , 2001, Investigative radiology.

[49]  W. Brooks,et al.  Biochemical markers of intelligence: a proton MR spectroscopy study of normal human brain , 1999, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[50]  M. Catani,et al.  Proton Magnetic Resonance Spectroscopy Reveals Similar White Matter Biochemical Changes in Patients with Chronic Hypertension and Early Alzheimer's Disease , 2002, Journal of the American Geriatrics Society.

[51]  Peter M. G. Munro,et al.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. , 1996, Neuroreport.

[52]  R. Ledeen,et al.  Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.

[53]  E. Weigl,et al.  On the psychology of so-called processes of abstraction. , 1941 .

[54]  D. Mathalon,et al.  A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. , 1994, Archives of neurology.

[55]  I. Marshall,et al.  Reproducibility of metabolite peak areas in 1H MRS of brain. , 1996, Magnetic resonance imaging.

[56]  D T Lowenthal,et al.  1H‐MRS, MRI‐Based Hippocampal Volumetry, and 99mTc‐HMPAO‐SPECT in Normal Aging, Age‐Associated Memory Impairment, and Probable Alzheimer's Disease , 1996, Journal of the American Geriatrics Society.

[57]  G J Barker,et al.  A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. , 2000, Magnetic resonance imaging.